安康怀孕得症状安康检查b超,安康下面有水和白带是怎么回,安康产科检查,安康不来例假怎么回事,安康阴部瘙痒,安康如何产后恢复,安康女子下腹疼痛

SAN FRANCISCO, April 4 (Xinhua) -- Web exploit toolkits, or " packaged" attack frameworks that can be traded online, are rapidly growing as the top cybercrime weapon due to ease of use and high success rate, a new report has found."When it comes to conducting online crime, exploit toolkits are the weapon of choice for many cyber criminals," said the "2010 Top Cyber Security Risks Report" published by Hewlett-Packard Co. (HP) on Monday.The trend started in 2006 with the release of WebAttacker, considered by many to be the first modern day web exploit toolkit, according to the report.An emerging trend ensued and soon took off, and today the Internet is subjected to hundreds of exploits originating from these toolkits."With the ever-increasing, web-based criminal activity, the number of exploit toolkits has skyrocketed and shows no signs of slowing down," the report stated.Though protecting against attacks originated with web exploit toolkits is becoming increasingly difficult, there are ways to minimize the risk of infection, said the report, noting that one of the most effective defenses is to install patches onto host systems.The report also found that while the number of attacks against known vulnerabilities continues to rise, the number of discovered vulnerabilities has plateaued in 2010."We've discovered that rather than investing resources to uncover new exploits, attackers are focused on current, unpatched vulnerabilities in web applications, social networking sites and Web 2.0 interfaces," Mike Dausin, a manager at HP Digital Vaccine Labs, said in a statement.Data from the report showed that nearly half of all reported vulnerabilities exist in web applications, and third-party plug- ins to content management systems have become the leading cause of web application vulnerabilities.

LOS ANGELES, April 3 (Xinhua) -- People with lower levels of vitamin D are more likely to have stiffer arteries and an inability of blood vessels to relax, U.S. researchers have found.This finding also applies to people who are in general good health, according to researchers from the Emory University School of Medicine.The researchers presented their findings on Sunday at the annual American College of Cardiology meeting in New Orleans.Impaired vascular health in correlation with lower vitamin D levels contributes to high blood pressure and the risk of cardiovascular disease, the researchers say.The study involved 554 participants, with the average age of 47 and generally healthy.The average level of 25-hydroxyvitamin D (a stable form of the vitamin reflecting diet as well as production in the skin) in participants' blood was 31.8 nanograms per milliliter. In this group, 14 percent had 25-hydroxyvitamin D levels considered deficient, or less than 20 nanograms per milliliter, and 33 percent had levels considered insufficient, less than 30 nanograms per milliliter.The researchers monitored the ability of participants' blood vessels to relax by inflating and then removing a blood pressure cuff on their arms. To allow blood to flow back into the arm, blood vessels must relax and enlarge -- a change that can be measured by ultrasound. The researchers also made other measurements of smaller blood vessels and examined the resistance to blood flow imposed by the arteries.

TIANJIN, April 16 (Xinhua) -- As China tries to establish a universal medicare umbrella, its first move to offer treatment to all the hemophilia patients in the country is to know their population and where they are.China's national hemophilia information management center registered 7,980 cases nationwide since its establishment last year in a bid to provide reference for making national treatment policies and medicine production quota, said the center officials Saturday.Yang Renchi with the center and the Chinese Academy of Medical Sciences, said that the patient information database will help the government make hemophilia-related medical and social welfare policies, optimize resources and guide the manufacturing of drugs such as coagulation factor VIII.The information center, created by the Ministry of Health, is located in the Blood Diseases Hospital of the Chinese Academy of Medical Sciences in the port city Tianjin in north China.Hemophilia is a rare genetic bleeding disorder that prevents the blood from clotting properly, resulting in easy bruising and prolonged bleeding from trauma. Lack of treatment can lead to permanent disabilities or even death.China is estimated to have roughly 100,000 hemophilia patients."Be inspired; get involved in Treatment for All" is the theme for the 22nd World Hemophilia Day, which falls on Sunday, April 17."A necessary precondition for 'Treatment for All' is to know the clinical information and location of each case," said Yang, "and this is exactly what the information system does."In addition, China plans to establish hospital-based provincial hemophilia management centers within five years across the country to register and monitor patients and standardize disease diagnosis and treatment under the information system.SHORTAGE OF DRUGSBlood-derived coagulation factor VIII and recombinant coagulation factor VIII are two effective drugs which are vital for hemophiliacs. However, the drugs are expensive and produced in limited quantities, a difficulty which hundreds of thousands of hemophiliacs in China have to confront.According to Yang, the minimum dose of coagulation factor VIII for prevention of bleeding episodes is two international units (IU) per kg of weight a day. A 50-kg hemophilia patient needs at least 36,500 IU of factor VIII every year to prevent bleeding."Each IU of blood-derived coagulation factor VIII costs about 3 yuan(0.46 U.S. dollars) and the annual cost is almost 120,000 yuan. The recombinant one is almost twice the price," said Yang.Only four drug firms are qualified to manufacture blood-derived coagulation factor VIII in China. The national output in 2010 was 400,000 vials (200 IU per vial) which means 80 million IU for the entire country.Wu Runhui, a hematology specialist with the Beijing Children's Hospital, said that the minimum dose is only for the prevention of bleeding episodes which are required to keep the patient alive. For the hemophiliac to live a regular lifestyle, 3,000 IU per kilo a year is needed, which would cost half a million yuan a year."Even in the most developed countries, a hemophiliac cannot survive without supportive medical policies and social welfare system," said Wu.

LOS ANGELES, April 11 (Xinhua) -- Drinking 100-percent fruit juice may offer disease-fighting benefits, a new study suggests.Fruit juice is linked with reduced risk of cancer, improved markers of heart health and cognitive decline, and increased antioxidant activity, according to the study published on Monday by the American Association for the Advancement of Science (AAAS).These protective health benefits are similar to those of whole fruits, said the study, conducted by researchers at the University of California, Davis.The researchers came to the conclusion after summarizing recent research data on the potential benefits of fruit juice. The review included a range of study types, from in vitro to clinical trials (60 papers total), all published in 2005 or later.Among the fruit juices included in the review, consumption of apple, citrus, cranberry, grape, and pomegranate juices all showed beneficial effects. Markers of improved health ranged from reductions in urinary tract infections (cranberry) to improvements in age-related cognitive decline (grape and apple) to reduced risk of prostate (pomegranate) and respiratory and digestive (orange, grapefruit) cancers. Additionally, intake of all juices was linked to heightened antioxidant activity."While it is universally accepted that fruit and vegetable intake is protective, there is not a clear consensus about the benefits of consuming the juices that are extracted from them," said study lead author Dianne Hyson, PhD. "An analysis of the scientific evidence suggests that 100 percent fruit juices retain important bioactive components that may promote good health and aid in disease prevention."

BEIJING, April 14 (Xinhuanet) -- Computer sales declined in the first three months of this year for the first time since 2009 worldwide.PC sales fell 1.1 percent in the first quarter to 84.3 million worldwide, according to tech research firm Gartner Wednesday, well short of its forecast for 3 percent growth.The dip was the first since the second quarter of 2009, when most of the world was still in the grip of economic turmoil."Although the first quarter is traditionally a slow one for PC sales, these shipment results indicate potential sluggishness, not just a normal seasonal slowdown," said Gartner, in a statement.Consumers select IT products at an IT fair named "Sham Shui Po computer festival" in Hong Kong, south China, Feb. 15, 2011. The eight-day IT fair kicked off here Monday. Some 600,000 people are predicted to visit the fair.Weak demand for consumer PCs was the biggest drag on the market, according to Gartner principal analyst Mikako Kitagawa."Low prices for consumer PCs, which had long stimulated growth, no longer attracted buyers," Kitagawa said."Instead, consumers turned their attention to media tablets and other consumer electronics."After Apple's second-generation iPad was released in February, many consumers either switched allegiances or simply held back from buying PCs, according to the analyst.Japan was a particularly weak spot, with PC sales falling 13 percent in the quarter, as people focused on getting back to normal after the March 11 earthquake and tsunami rather than spending money on new technology.